Key Data on Ovarian Cancer From ESGO 2023 Key Data on Ovarian Cancer From ESGO 2023

Kathleen Moore, MD, discusses ovarian cancer data from ESGO 2023 that suggest variations in BRCA mutations may affect frontline therapy, the benefits of secondary hyperthermic intraperitoneal chemo, and important data from MIRASOL.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news